AU2006240038B2 - Materials and methods for respiratory disease control in canines - Google Patents

Materials and methods for respiratory disease control in canines Download PDF

Info

Publication number
AU2006240038B2
AU2006240038B2 AU2006240038A AU2006240038A AU2006240038B2 AU 2006240038 B2 AU2006240038 B2 AU 2006240038B2 AU 2006240038 A AU2006240038 A AU 2006240038A AU 2006240038 A AU2006240038 A AU 2006240038A AU 2006240038 B2 AU2006240038 B2 AU 2006240038B2
Authority
AU
Australia
Prior art keywords
amino acid
seq
acid sequence
virus
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006240038A
Other languages
English (en)
Other versions
AU2006240038A1 (en
Inventor
William L. Castleman
Nancy J. Cox
Patti C. Crawford
Ruben O. Donis
Edward J. Dubovi
Paul J. Gibbs
Jacqueline Katz
Alexander I. Klimov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Centers of Disease Control and Prevention CDC
University of Florida Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
University of Florida
Centers of Disease Control and Prevention CDC
University of Florida Research Foundation Inc
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc, University of Florida, Centers of Disease Control and Prevention CDC, University of Florida Research Foundation Inc, US Department of Health and Human Services filed Critical Cornell Research Foundation Inc
Publication of AU2006240038A1 publication Critical patent/AU2006240038A1/en
Assigned to UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC., THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION, CORNELL RESEARCH FOUNDATION, INC. reassignment UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: CENTERS FOR DISEASE CONTROL & PREVENTION CDC, TECHNOLOGY TRANSFER OFFICE, CORNELL RESEARCH FOUNDATION, INC., UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Application granted granted Critical
Publication of AU2006240038B2 publication Critical patent/AU2006240038B2/en
Priority to AU2012238228A priority Critical patent/AU2012238228B2/en
Priority to AU2018201367A priority patent/AU2018201367B2/en
Priority to AU2020233708A priority patent/AU2020233708B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2006240038A 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines Ceased AU2006240038B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2012238228A AU2012238228B2 (en) 2005-04-21 2012-10-05 Materials and methods for respiratory disease control in canines
AU2018201367A AU2018201367B2 (en) 2005-04-21 2018-02-26 Materials and methods for respiratory disease control in canines
AU2020233708A AU2020233708B2 (en) 2005-04-21 2020-09-17 Materials and methods for respiratory disease control in canines

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67344305P 2005-04-21 2005-04-21
US60/673,443 2005-04-21
PCT/US2006/015090 WO2006116082A1 (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012238228A Division AU2012238228B2 (en) 2005-04-21 2012-10-05 Materials and methods for respiratory disease control in canines

Publications (2)

Publication Number Publication Date
AU2006240038A1 AU2006240038A1 (en) 2006-11-02
AU2006240038B2 true AU2006240038B2 (en) 2012-07-05

Family

ID=37215064

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006240038A Ceased AU2006240038B2 (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Country Status (16)

Country Link
EP (3) EP2495326B1 (OSRAM)
JP (6) JP2008536526A (OSRAM)
KR (3) KR101738940B1 (OSRAM)
CN (3) CN103451158B (OSRAM)
AU (1) AU2006240038B2 (OSRAM)
BR (2) BRPI0610503B1 (OSRAM)
CA (1) CA2606429A1 (OSRAM)
ES (1) ES2570758T3 (OSRAM)
IL (3) IL186710A (OSRAM)
MX (3) MX358750B (OSRAM)
NO (2) NO345667B1 (OSRAM)
NZ (2) NZ583564A (OSRAM)
RU (2) RU2449014C2 (OSRAM)
SG (2) SG10201910006WA (OSRAM)
WO (1) WO2006116082A1 (OSRAM)
ZA (1) ZA200708897B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
NZ583564A (en) * 2005-04-21 2011-09-30 Univ Florida Materials and Methods For Respiratory Disease Control in Canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
WO2006121773A2 (en) 2005-05-06 2006-11-16 Gen-Probe Incorporated Compositions and assays to detect influenza virus a and b nucleic acids
US7425336B2 (en) * 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
WO2007042884A1 (en) * 2005-10-07 2007-04-19 Pfizer Products Inc. Vaccines and methods to treat canine influenza
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
EP2407480B1 (en) * 2005-10-19 2014-07-16 University of Florida Research Foundation, Incorporated Materials for respiratory disease control in canines
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2076280B1 (en) * 2006-10-25 2019-07-10 Intervet International BV Feline influenza vaccine and method of use
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
EP2953967B1 (en) * 2013-02-07 2019-05-01 Massachusetts Institute of Technology Human adaptation of h5 influenza
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
US20180187273A1 (en) * 2015-07-02 2018-07-05 Indevr Inc. Universal Priming Mixture for Amplification of Influenza Viral Gene Segments for Diagnostic Applications
BR112021024409A2 (pt) * 2019-06-07 2022-01-18 Intervet Int Bv Célula mutante nocaute de mdbk irf3/irf7 e seu uso para produção de vacina
CN110592276A (zh) * 2019-07-08 2019-12-20 北京世纪元亨动物防疫技术有限公司 用于检测犬流感病毒的特异性引物及试剂盒
CN115074461B (zh) * 2021-03-11 2023-08-25 上海市农业科学院 犬流感病毒、犬冠状病毒和犬呼肠孤病毒的三重pcr检测方法
CN115725517A (zh) * 2022-09-01 2023-03-03 军事科学院军事医学研究院军事兽医研究所 一种h3n2犬流感重组病毒株及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
RU2193065C2 (ru) * 1994-03-14 2002-11-20 Мерк энд Ко. Инк. Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
CA2182888C (en) * 1994-03-30 2007-08-07 Enzo Paoletti Nucleotide and amino acid sequences of canine herpesvirus gb, gc and gd and uses therefor
GB9524395D0 (en) 1995-11-29 1996-01-31 Nickerson Biocem Ltd Promoters
US6252139B1 (en) 1996-07-18 2001-06-26 The Salk Institute For Biological Studies Method of increasing growth and yield in plants
US6063385A (en) 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
US6472375B1 (en) 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
AU762798B2 (en) 1998-11-24 2003-07-03 Pioneer Hi-Bred International, Inc. Root-preferred promoters and their use
JP2000230931A (ja) * 1998-12-07 2000-08-22 Katakura Industries Co Ltd 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット
DE19960843A1 (de) 1999-12-16 2001-06-28 Florian Grundler Wurzelspezifischer Promotor
AU2001259211B2 (en) * 2000-04-28 2006-07-13 St. Jude Children's Research Hospital DNA transfection system for the generation of infectious influenza virus
MXPA02012255A (es) * 2000-06-23 2003-04-25 American Cyanamid Co Secuencia de nucleotidos del genoma a/udorn/72(hen2) de influenza.
US6455760B1 (en) 2000-11-16 2002-09-24 The Salk Institute Of Biological Studies Expression of flavin-containing monoxygenases in plants
US20040067506A1 (en) 2000-12-04 2004-04-08 Ben Scheres Novel root specific promoter driving the expression of a novel lrr receptor-like kinase
AU2002253542B2 (en) * 2002-04-12 2007-06-07 Ilaria Capua Purified subfragment encoding neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
US7285656B2 (en) 2002-04-26 2007-10-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Root-specific conifer gene promoter and its use
WO2004028471A2 (en) * 2002-09-28 2004-04-08 Massachusetts Institute Of Technology Influenza therapeutic
WO2004057021A2 (en) * 2002-12-19 2004-07-08 UNIVERSITé LAVAL Molecular methods and compositions for detecting and quantifying respiratory viruses
US20040123349A1 (en) 2002-12-20 2004-06-24 Qi Xie SINAT5, an Arabidopsis thaliana gene promotes ubiquitin related degradation
BRPI0410091A (pt) * 2003-05-15 2006-06-06 Univ Oklahoma State vacina para vìrus influenza eqüina, e, método para induzir uma resposta imune contra vìrus influenza eqüina
CN1458168A (zh) * 2003-06-02 2003-11-26 中国农业科学院哈尔滨兽医研究所 重组猪流感病毒np抗原、其制备方法及在诊断中的应用
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
NZ583564A (en) * 2005-04-21 2011-09-30 Univ Florida Materials and Methods For Respiratory Disease Control in Canines
WO2007042884A1 (en) * 2005-10-07 2007-04-19 Pfizer Products Inc. Vaccines and methods to treat canine influenza
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
EP2407480B1 (en) * 2005-10-19 2014-07-16 University of Florida Research Foundation, Incorporated Materials for respiratory disease control in canines
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OHWADA, K. et al., 'Microbiology and immunology, 1986, vol. 30, no. 5, pages 451-460 *
University of Florida News, '2004. URL: http://news.ufl.edu/2004/04/22/racedogflu/ *

Also Published As

Publication number Publication date
CN107099512A (zh) 2017-08-29
CA2606429A1 (en) 2006-11-02
NZ562661A (en) 2010-04-30
NO20180601A1 (no) 2008-01-21
IL186710A (en) 2017-09-28
SG10201910006WA (en) 2019-11-28
JP2013031440A (ja) 2013-02-14
JP6301855B2 (ja) 2018-03-28
KR101738937B1 (ko) 2017-05-23
CN103451158A (zh) 2013-12-18
RU2020100038A (ru) 2021-07-09
JP6042131B2 (ja) 2016-12-14
JP2018050636A (ja) 2018-04-05
BRPI0610503A2 (pt) 2010-06-29
EP1871885A4 (en) 2009-09-16
EP2495326A2 (en) 2012-09-05
KR101474011B1 (ko) 2014-12-23
EP2489739A2 (en) 2012-08-22
KR101738940B1 (ko) 2017-06-08
KR20140091770A (ko) 2014-07-22
MX2018010571A (es) 2022-01-25
MX358750B (es) 2018-08-31
NO345667B1 (no) 2021-06-07
KR20080039836A (ko) 2008-05-07
CN101253267A (zh) 2008-08-27
NO20075961L (no) 2008-01-21
IL208707A0 (en) 2010-12-30
ES2570758T3 (es) 2016-05-20
RU2711791C2 (ru) 2020-01-22
IL249236A0 (en) 2017-01-31
EP1871885B8 (en) 2017-08-02
KR20150082628A (ko) 2015-07-15
BRPI0610503B1 (pt) 2022-05-31
RU2011153597A (ru) 2013-07-10
JP2008536526A (ja) 2008-09-11
EP2495326B1 (en) 2019-11-20
MX339202B (es) 2016-05-13
EP2489739B1 (en) 2019-11-20
AU2006240038A1 (en) 2006-11-02
WO2006116082A1 (en) 2006-11-02
JP6663416B2 (ja) 2020-03-11
RU2449014C2 (ru) 2012-04-27
HK1111729A1 (zh) 2008-08-15
ZA200708897B (en) 2009-01-28
SG10201406043TA (en) 2014-11-27
RU2007143041A (ru) 2009-05-27
JP2024043541A (ja) 2024-03-29
EP1871885A1 (en) 2008-01-02
EP1871885B1 (en) 2016-02-17
IL249236B (en) 2021-07-29
JP2015144604A (ja) 2015-08-13
BR122018012345B1 (pt) 2021-10-26
NO342494B1 (no) 2018-06-04
EP2495326A3 (en) 2013-08-28
NZ583564A (en) 2011-09-30
IL186710A0 (en) 2008-02-09
JP2020031658A (ja) 2020-03-05
CN103451158B (zh) 2018-11-23
EP2489739A3 (en) 2013-08-28
IL208707B (en) 2020-01-30

Similar Documents

Publication Publication Date Title
US11160859B2 (en) Materials and methods for respiratory disease control in canines
AU2006240038B2 (en) Materials and methods for respiratory disease control in canines
AU2006304747B2 (en) Influenza viruses able to infect canids, uses thereof
AU2020264347B2 (en) Influenza viruses able to infect canids, uses thereof
AU2020233708B2 (en) Materials and methods for respiratory disease control in canines
US11865172B2 (en) Materials and methods for respiratory disease control in canines
HK1173189A (en) Materials and methods for respiratory disease control in canines
HK1174061A (en) Materials and methods for respiratory disease control in canines
HK1174061B (en) Materials and methods for respiratory disease control in canines
HK1111729B (en) Materials and methods for respiratory disease control in canines
HK1173189B (en) Materials and methods for respiratory disease control in canines
HK1118563B (en) Influenza viruses able to infect canids, uses thereof

Legal Events

Date Code Title Description
CB Opposition filed

Opponent name: PICKERING, W.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired